Regulatory Strategies for Dx-Rx Approvals for Gene Therapies & Impact of Marketing Requirements

• Current regulatory challenges for Dx-Rx co-development in GT
• Strategies for approval for GT diagnostics
• EU and US payer’s policies impact on regulatory decision making in GT diagnostics

Speakers:

Adriana Racolta

Senior Director, Global Regulatory Leader, IVD

Bayer